Glenmark launches hypertension drug fosinopril sodium in US

Glenmark Generics Inc, USA (GGI), the US subsidiary of Glenmark Generics Limited and a leading company in the manufacture, marketing and distribution of high-quality, low-cost generic pharmaceutical products in the US, initiated the launch of fosinopril sodium and hydrochlorothiazide tablets in the US market. 

Fosinopril sodium and hydrochlorothiazide (HCTZ) tablets are available in both 10mg/12.5mg and 20mg/12.5mg strengths and are indicated for the treatment of hypertension. Glenmark's product is the AB rated therapeutic equivalent of Bristol Myers Squibb's Monopril-HCT. Overall generic market sales for the product is approximately USD 10 million for the 12 month period ending March 2009, according to IMS Health Data. 


Popular posts from this blog

GOP Senator says it's hard to fund $14 billion children's health care program — then advocates for $1 trillion tax cut

Trump wants more mental health care; Alabama says it's trying